MGTX MeiraGTx

• None no insider bought on the open market
• None no sales outside a trading plan
• $4.7M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Richard Giroux CFO
   Planned sale
   $557K 56,000 shares at $9.95 6.2% of stake
   Traded Oct 20 Filed Oct 20
   ↗
3. Stuart Naylor Chief Sci Ofcr, Ophthalmology
   Planned sale
   $294K 27,659 shares at $10.64 4.3% of stake
   Traded Oct 6 Filed Oct 6
   ↗
4. Alexandria Forbes CEO
   Planned sale
   $859K 62,000 shares at $13.86 4.5% of stake
   Traded Aug 18 Filed Aug 18
   ↗
5. Richard Giroux CFO
   Planned sale
   $701K 56,000 shares at $12.51 5.8% of stake
   Traded Jul 21 Filed Jul 21
   ↗
6. Stuart Naylor Chief Sci Ofcr, Ophthalmology
   Planned sale
   $409K 27,659 shares at $14.80 4.1% of stake
   Traded Jul 7 Filed Jul 7
   ↗
7. Alexandria Forbes CEO
   Planned sale
   $569K 62,000 shares at $9.17 4.3% of stake
   Traded May 19 Filed May 19
   ↗
8. Richard Giroux CFO
   Planned sale
   $572K 56,000 shares at $10.22 5.4% of stake
   Traded Apr 21 Filed Apr 21
   ↗
9. Stuart Naylor Chief Dev. Officer
   Planned sale
   $259K 27,661 shares at $9.36 4% of stake
   Traded Apr 7 Filed Apr 7
   ↗
10. Alexandria Forbes CEO
    Planned sale
    $459K 62,000 shares at $7.41 4.1% of stake
    Traded Mar 24 Filed Mar 24
    ↗
11. Richard Giroux CFO
    Planned sale
    $213K 24,000 shares at $8.87 2.8% of stake
    Traded Oct 21, 2025 Filed Oct 21, 2025
    ↗
12. Alexandria Forbes CEO
    Planned sale
    $399K 47,500 shares at $8.39 3.5% of stake
    Traded Oct 7, 2025 Filed Oct 7, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 16 option exercises, 15 share withholdings for taxes, 3 gifts, 1 stock grant, and 1 sale back to the company.